US Tech 100

19,573.60

0.48%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AMGN

Amgen (AMGN)

Amgen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:BIT:AMGN

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
02/08/2010	6:20PM	PR Newswire (US)	Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Me	NASDAQ:AMGN
01/25/2010	4:07PM	PR Newswire (US)	Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share	NASDAQ:AMGN
01/21/2010	9:00AM	PR Newswire (US)	Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium	NASDAQ:AMGN
01/20/2010	4:13PM	PR Newswire (US)	Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results	NASDAQ:AMGN
01/14/2010	12:57PM	PR Newswire (US)	Amgen Donates $2 Million, Establishes Earthquake Relief Program	NASDAQ:AMGN
01/07/2010	4:34PM	PR Newswire (US)	Amgen to Present at the 28th Annual JP Morgan Healthcare Conference	NASDAQ:AMGN
12/22/2009	4:04PM	PR Newswire (US)	Amgen Resolves EPO Patent Dispute With Roche	NASDAQ:AMGN
12/18/2009	4:40PM	PR Newswire (US)	Amgen's Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines	NASDAQ:AMGN
12/07/2009	9:01AM	PR Newswire (US)	Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program	NASDAQ:AMGN
12/03/2009	1:04PM	PR Newswire (US)	New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists	NASDAQ:AMGN
11/30/2009	8:51AM	PR Newswire (US)	Amgen Highlights Data to be Presented at ASH	NASDAQ:AMGN
11/23/2009	3:05PM	PR Newswire (US)	Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards	NASDAQ:AMGN
11/16/2009	6:06PM	PR Newswire (US)	Amgen to Present at Lazard Capital Healthcare Conference	NASDAQ:AMGN
11/12/2009	9:01AM	PR Newswire (US)	Amgen to Present at 18th Annual Credit Suisse Healthcare Conference	NASDAQ:AMGN
11/05/2009	8:03AM	PR Newswire (US)	Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer	NASDAQ:AMGN
11/04/2009	12:22PM	PR Newswire (US)	Call for Applications: The Amgen Award for Science Teaching Excellence	NASDAQ:AMGN
10/30/2009	8:44PM	PR Newswire (US)	Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medic	NASDAQ:AMGN
10/21/2009	4:08PM	PR Newswire (US)	Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to $1.49	NASDAQ:AMGN
10/19/2009	2:57PM	Dow Jones News	2nd UPDATE: FDA Delays Decision On Amgen Bone Drug	NASDAQ:AMGN	Amgen Inc.
10/19/2009	11:17AM	Dow Jones News	UPDATE: FDA Delays Decision On Amgen Bone Drug For Added Info	NASDAQ:AMGN	Amgen Inc.
10/19/2009	9:55AM	Dow Jones News	FDA Seeks Added Info On Amgen Bone Drug, Delays Decision	NASDAQ:AMGN	Amgen Inc.
10/16/2009	2:55PM	Dow Jones News	US EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 Launches	NASDAQ:AMGN	Amgen Inc.
10/15/2009	4:42PM	PR Newswire (US)	Amgen Announces Webcast of 2009 Third Quarter Financial Results	NASDAQ:AMGN
10/14/2009	2:44PM	Dow Jones News	Amgen's Bone Drug May Face Delays In FDA Decision	NASDAQ:AMGN	Amgen Inc.
10/12/2009	10:57AM	Dow Jones News	Drug Stocks Edge Higher; DepoMed Sinks	NASDAQ:AMGN	Amgen Inc.
10/01/2009	1:22PM	Dow Jones News	Hospira Learning Valuable Lessons In European Biosimilar Market	NASDAQ:AMGN	Amgen Inc.
09/24/2009	3:37AM	PR Newswire (US)	Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorecta	NASDAQ:AMGN
09/23/2009	10:22AM	Dow Jones News	Conflicting Erbitux Study Data Hurts Merck Shares	NASDAQ:AMGN	Amgen Inc.
09/23/2009	5:59AM	Dow Jones News	Merck Shares Rise On Positive Erbitux Data For Colon Cancer	NASDAQ:AMGN	Amgen Inc.
09/22/2009	7:28AM	Dow Jones News	Amgen's Denosumab Aids Bones In Breast-Cancer Patients	NASDAQ:AMGN	Amgen Inc.